Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORKID: Outpatient Recovery From AKI Requiring Dialysis
NCT05158153Phase 4Terminated
- Sponsor
- University of California, San Francisco
- Start
- Oct 2021
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide in acute kidney injury (AKI), sponsored by University of California, San Francisco. Started Oct 2021; status: terminated.
02
Drugs
furosemide
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05158153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05158153.